Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders
- PMID: 33160961
- DOI: 10.1016/j.yexmp.2020.104566
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders
Abstract
Over the past decades, new light has been shed on the efficiency of Mesenchymal Stem Cells (MSCs) in the treatment of autoimmune diseases. The therapeutic functions of MSCs partly stem from their well-recognized ability to efficiently modulate immune responses and it is well substantiated that MSC secretory components, in particular extracellular vesicles (EVs), play a critical role in this immunomodulation. In fact, almost any cell type can generate and release EVs under both pathological and physiological conditions and these nano-sized particles are believed to greatly contribute to homeostasis and cell-cell communication through transportation of a wide variety of biomolecules including nucleic acid, signaling lipids, regulatory proteins, transcription factors, cytokines, and growth factors. Lamentably, despite exhibiting promising results in both animal experiments and clinical trials, MSC therapy is still largely restricted to the experimental stage due to its critical pitfalls and drawbacks such as safety issues, poor cell survival, immune rejection and high cost. On the other hand, MSC-derived EVs, which ideally reflect the exact biophysical features of MSCs, are considered to be much safer and more effective than MSCs themselves. Therefore, introducing alternative approaches based on MSC-derived EVs can offer appreciable promise in overcoming the limitations and practical challenges observed in cell-based therapy and thus the extracellular vesicles of MSCs may also provide a far more potent therapeutic strategy for immune-related disorders. In this review, we first focus on the properties of MSC-derived EVs and then we shall provide valuable insight regarding their beneficial therapeutic opportunities to further compare this alternative approach with conventional MSC therapy. Finally, we will attempt to summarize the current findings on the influences of MSC-derived EVs on autoimmune disorders, offering a potential alternative avenue towards treatment of autoimmune diseases.
Keywords: Autoimmune diseases; Cell free therapy; Extracellular vesicles; MSC-derived EVs; Mesenchymal stem cells.
Copyright © 2020. Published by Elsevier Inc.
Similar articles
-
Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications.Int J Mol Sci. 2021 Sep 20;22(18):10132. doi: 10.3390/ijms221810132. Int J Mol Sci. 2021. PMID: 34576296 Free PMC article. Review.
-
Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles.Mol Biol Rep. 2019 Feb;46(1):1533-1549. doi: 10.1007/s11033-019-04588-y. Epub 2019 Jan 8. Mol Biol Rep. 2019. PMID: 30623280 Review.
-
The developing role of extracellular vesicles in autoimmune diseases: special attention to mesenchymal stem cell-derived extracellular vesicles.Int Immunopharmacol. 2023 Sep;122:110531. doi: 10.1016/j.intimp.2023.110531. Epub 2023 Jul 10. Int Immunopharmacol. 2023. PMID: 37437434 Review.
-
Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.J Trauma Acute Care Surg. 2018 Feb;84(2):245-256. doi: 10.1097/TA.0000000000001744. J Trauma Acute Care Surg. 2018. PMID: 29251710 Free PMC article.
-
Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis.Cell Tissue Res. 2018 Oct;374(1):1-15. doi: 10.1007/s00441-018-2871-5. Epub 2018 Jun 28. Cell Tissue Res. 2018. PMID: 29955951 Review.
Cited by
-
The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles.Stem Cell Res Ther. 2022 Jun 7;13(1):242. doi: 10.1186/s13287-022-02929-6. Stem Cell Res Ther. 2022. PMID: 35672797 Free PMC article. Review.
-
Therapeutic Application of Exosomes in Inflammatory Diseases.Int J Mol Sci. 2021 Jan 24;22(3):1144. doi: 10.3390/ijms22031144. Int J Mol Sci. 2021. PMID: 33498928 Free PMC article. Review.
-
News About the Extracellular Vesicles from Mesenchymal Stem Cells: Functions, Therapy and Protection from COVID-19.J Exp Pathol (Wilmington). 2021;2(1):47-52. doi: 10.33696/pathology.2.015. J Exp Pathol (Wilmington). 2021. PMID: 33786534 Free PMC article.
-
Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success.Biomedicines. 2021 Jun 10;9(6):667. doi: 10.3390/biomedicines9060667. Biomedicines. 2021. PMID: 34200818 Free PMC article. Review.
-
Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer.Theranostics. 2022 Oct 9;12(16):7080-7107. doi: 10.7150/thno.75937. eCollection 2022. Theranostics. 2022. PMID: 36276645 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous